We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
110 hedge funds and large institutions have $272M invested in Zevra Therapeutics in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
43% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 30
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
15% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 13
2% more ownership
Funds ownership: 63.56% → 65.55% (+2%)
1% more funds holding
Funds holding: 109 → 110 (+1)
4% less capital invested
Capital invested by funds: $283M → $272M (-$11.4M)
46% less call options, than puts
Call options by funds: $2.76M | Put options by funds: $5.07M
Holders
110
Holders Change
+1
Holders Change %
+0.92%
% of All Funds
1.48%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
15
Increased
43
Reduced
30
Closed
13
Calls
$2.76M
Puts
$5.07M
Net Calls
-$2.31M
Net Calls Change
-$5.72M
Top Buyers
Top Sellers
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$6.9M |
| 2 |
ACM
Altium Capital Management
New York
|
-$4.47M |
| 3 |
JGC
J. Goldman & Co
New York
|
-$3.07M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.44M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.44M |
